Featured 13F manager
DME Capital Management David Einhorn
New York, NY 20 processed 13Fs on this site · 2021 Q3–2026 Q2
- $3.9B
- 46 holds
- 2026 Q2
- +22.5% QoQ
- Top 5 38.2%
David Einhorn files DME Capital Management as a Form 13F. The latest book is 2026 Q2 at $3.9B, up 22.5% QoQ, led by Green Brick Partners, Fluor, and Core Natural Resources.
Portfolio
top 5 38.2% · top 10 52.8%
- GRBK - Green Brick Partners 19.4%
- FLR - Fluor 6.2%
- CNR - Core Natural Resources 4.7%
- BHF - Brighthouse Finl 4.6%
- ACHC — 3.3%
- PENN - Penn Entertainment 3.2%
- FBIN - Fortune Brands 3.1%
- PCG - Pg And E 2.9%
- CNC - Centene Del 2.7%
- PKG - Graphic Packaging 2.7%
- SNX - Td Synnex 2.6%
- TEVA - Teva Pharmaceutical Inds 2.5%
- Other 42.1%
AUM over time
Book
| GRBK - Green Brick Partners | Hold | 9,467,383 | $56.49 | $535M | — | — | |
| CEIXEUR - Consol Energy | Reduce −15.0% | 1,394,641 | $106.68 | $149M | −246,109 | −$23M | |
| BHF - Brighthouse Finl | Reduce −2.0% | 2,835,097 | $48.04 | $136M | −56,952 | +$6M | |
| KD - Kyndryl | Reduce −23.6% | 3,762,442 | $34.60 | $130M | −1,161,907 | +$17M | |
| CNH - Cnh Indl | Add +44.2% | 10,234,720 | $11.33 | $116M | +3,137,820 | +$37M | |
| PENN - Penn Entertainment | Add +2.3% | 5,748,440 | $19.82 | $114M | +127,670 | +$8M | |
| PTON - Peloton Interactive · CL A | Add +10.4% | 10,522,687 | $8.70 | $92M | +992,797 | +$47M | |
| VTRS - Viatris | Reduce −20.4% | 5,785,110 | $12.45 | $72M | −1,485,320 | −$12M | |
| HPQ - HP | Reduce −40.2% | 2,110,680 | $32.63 | $69M | −1,420,210 | −$58M | |
| ROIV - Roivant Sciences | Reduce −0.7% | 5,271,067 | $11.83 | $62M | −36,973 | +$1M | |
| CNC - Centene Del | New | 870,500 | $60.58 | $53M | +870,500 | +$53M | |
| LBTYA - Liberty Global · CL A | Reduce −8.6% | 3,885,258 | $12.76 | $50M | −367,622 | −$40M | |
| GLD - Spdr Gold Tr | Reduce −3.2% | 201,941 | $242.13 | $49M | −6,740 | −$2M | |
| DHT — | Add +20.8% | 5,245,984 | $9.29 | $49M | +902,704 | +$829K | |
| CPRI - Capri | Add +93.6% | 2,103,717 | $21.06 | $44M | +1,017,072 | −$2M | |
| TECK - Teck Resources · CL B | Hold | 1,086,663 | $40.53 | $44M | — | — | |
| WFRD - Weatherford Intl | Add +157.5% | 456,639 | $71.63 | $33M | +279,300 | +$18M | |
| SDRL - Seadrill 2021 | Add +27.7% | 768,165 | $38.93 | $30M | +166,620 | +$6M | |
| PKG - Graphic Packaging | Hold | 1,047,100 | $27.16 | $28M | — | — | |
| ALITEUR - Alight · CL A | Reduce −71.7% | 3,353,026 | $6.92 | $23M | −8,493,184 | −$64M | |
| LKFT - Galapagos | Hold | 479,363 | $27.50 | $13M | — | — | |
| TEVA - Teva Pharmaceutical Inds | Add +44.2% | 468,550 | $22.04 | $10M | +143,700 | +$4M | |
| COYA - Coya Therapeutics | Add +29.2% | 1,646,440 | $5.73 | $9M | +372,414 | +$1M | |
| SNX - Td Synnex | New | 53,780 | $117.28 | $6M | +53,780 | +$6M | |
| ACHC — | New | 128,640 | $39.65 | $5M | +128,640 | +$5M | |
| RSP — | New | 27,530 | $175.23 | $5M | +27,530 | +$5M | |
| Spdr Ser Tr | New | 59,810 | $79.59 | $5M | +59,810 | +$5M | |
| GDX - Vaneck ETF Trust | Hold | 111,390 | $33.91 | $4M | — | — | |
| GPRO - Gopro · CL A | Hold | 2,823,100 | $1.09 | $3M | — | — | |
| FCG - First Tr Exchange-Traded Fd | Hold | 70,830 | $24.63 | $2M | — | — | |
| IVZ - Invesco Actvely Mngd Etc Fd | Hold | 117,360 | $12.99 | $2M | — | — | |
| OIH - Vaneck ETF Trust | Reduce −50.0% | 5,610 | $271.23 | $2M | −5,610 | −$2M | |
| GANX - Gain Therapeutics | Hold | 566,130 | $2.16 | $1M | — | — | |
| NUVB - Nuvation Bio · CL A | Hold | 34,995 | $2.66 | $93K | — | — |
Exits / last held
Not current holdings · last reported size, unchanged · gone vs 2024 Q3
| Stock | % of portfolio | Recent activity | Shares | Reported price* | Value | Share change | $ change |
|---|---|---|---|---|---|---|---|
| THC - Tenet Healthcare | Exit | 0 | $166.20 | $48M | −287,100 | −$48M | |
| ODP1 - The Odp | Exit | 0 | $29.75 | $48M | −1,600,000 | −$48M | |
| IAC - IAC Inc | Exit | 0 | $53.82 | $34M | −636,270 | −$34M | |
| LIVN - Livanova | Exit | 0 | $52.54 | $32M | −603,549 | −$32M | |
| RSP — | Exit | 0 | $114.97 | $21M | −182,511 | −$21M | |
| XAR - Spdr Ser Tr | Exit | 0 | $157.34 | $20M | −127,557 | −$20M | |
| Danimer Scientific · CL A | Exit | 0 | $0.4538 | $498K | −1,097,461 | −$498K |
Filings history
20 periods · normalized AUM · open a period for holdings
| Period | Holds | AUM | QoQ | Form | Filed | Filing ID |
|---|---|---|---|---|---|---|
| 2026 Q2 | 46 | $3.9B | +22.5% | 13F-HR | 8/14/2026 | 000117266126003786 |
| 2026 Q1 | 45 | $3.2B | +12.0% | 13F-HR | 5/15/2026 | 000117266126002341 |
| 2025 Q4 | 41 | $2.8B | +12.1% | 13F-HR | 2/17/2026 | 000117266126001122 |
| 2025 Q3 | 37 | $2.5B | +9.3% | 13F-HR | 11/14/2025 | 000117266125005032 |
| 2025 Q2 | 34 | $2.3B | +17.8% | 13F-HR | 8/14/2025 | 000117266125003351 |
| 2025 Q1 | 33 | $2B | +1.5% | 13F-HR | 5/15/2025 | 000117266125002307 |
| 2024 Q4 | 36 | $1.9B | −19.1% | 13F-HR | 2/14/2025 | 000117266125001165 |
| 2024 Q3 | 38 | $2.4B | +17.6% | 13F-HR | 11/14/2024 | 000117266124005240 |
| 2024 Q2 | 39 | $2B | −6.5% | 13F-HR | 8/14/2024 | 000117266124003549 |
| 2024 Q1 | 42 | $2.2B | — | 13F-HR | 5/15/2024 | 000117266124002489 |
| 2023 Q4 | 40 | $2B | +16.3% | 13F-HR | 2/14/2024 | 000117266124001512 |
| 2023 Q3 | 39 | $1.8B | −17.4% | 13F-HR | 11/14/2023 | 000117266123004012 |
| 2023 Q2 | 41 | $2.1B | +15.9% | 13F-HR | 8/14/2023 | 000117266123003174 |
| 2023 Q1 | 39 | $1.8B | +27.4% | 13F-HR | 5/15/2023 | 000117266123002282 |
| 2022 Q4 | 42 | $1.4B | +2.3% | 13F-HR | 2/14/2023 | 000117266123001336 |
| 2022 Q3 | 42 | $1.4B | +9.8% | 13F-HR | 11/14/2022 | 000117266122002565 |
| 2022 Q2 | 47 | $1.3B | −18.3% | 13F-HR | 8/15/2022 | 000117266122002019 |
| 2022 Q1 | 52 | $1.6B | −10.0% | 13F-HR | 5/16/2022 | 000117266122001474 |
| 2021 Q4 | 57 | $1.7B | +17.2% | 13F-HR | 2/14/2022 | 000117266122000884 |
| 2021 Q3 | 58 | $1.5B | — | 13F-HR | 11/15/2021 | 000117266121002370 |
About
DME Capital Management
20 processed 13Fs on this site · 2021 Q3–2026 Q2